CI DEF 14A DEF-14A Report April 22, 2020 | Alphaminr
Cigna Corp

CI DEF 14A Report ended April 22, 2020

TABLE OF CONTENTS
PROXY STATEMENT SUMMARYCORPORATE GOVERNANCE MATTERSELECTION OF DIRECTORS (PROPOSAL 1)DIRECTOR EXPECTATIONS AND QUALIFICATIONSNOMINATION PROCESSPROCESS FOR DIRECTOR ELECTIONSBOARD COMPOSITION DEVELOPMENTSCOMMITMENT TO BOARD DIVERSITYOTHER PRACTICESBOARD OF DIRECTORS NOMINEESCORPORATE GOVERNANCE POLICIES AND PRACTICESADOPTION OF SPECIAL MEETING RIGHT IN RESPONSE TO 2019 WRITTEN CONSENT SHAREHOLDER PROPOSALDIRECTOR INDEPENDENCEBOARD LEADERSHIP STRUCTUREBOARD EVALUATIONS AND BOARD EFFECTIVENESSRESPONSIBILITIES OF THE BOARDBOARD MEETINGS AND COMMITTEESCODES OF ETHICSCORPORATE RESPONSIBILITYANNUAL POLITICAL CONTRIBUTIONS AND LOBBYING ACTIVITY REPORTCERTAIN TRANSACTIONSNON-EMPLOYEE DIRECTOR COMPENSATIONOVERVIEWDIRECTOR COMPENSATION PROGRAMDIRECTOR COMPENSATION TABLE FOR 2019DIRECTOR OWNERSHIPCOMPENSATION MATTERSADVISORY APPROVAL OF EXECUTIVE COMPENSATION (PROPOSAL 2)COMPENSATION DISCUSSION AND ANALYSISEXECUTIVE SUMMARYPROCESSES AND PROCEDURES FOR DETERMINING EXECUTIVE COMPENSATIONEXECUTIVE COMPENSATION POLICIES AND PRACTICESELEMENTS OF COMPENSATIONEMPLOYMENT ARRANGEMENTS AND POST-TERMINATION PAYMENTSOTHER PRACTICESREPORT OF THE PEOPLE RESOURCES COMMITTEEEXECUTIVE COMPENSATION TABLES2019 SUMMARY COMPENSATION TABLEGRANTS OF PLAN-BASED AWARDS IN 2019OUTSTANDING EQUITY AWARDS AT YEAR-END 2019OPTION EXERCISES AND STOCK VESTED IN 2019PENSION BENEFITS FOR 2019NONQUALIFIED DEFERRED COMPENSATION FOR 2019POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROLAUDIT MATTERSRATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PROPOSAL 3)REPORT OF THE AUDIT COMMITTEESHAREHOLDER PROPOSALSSHAREHOLDER PROPOSAL SHAREHOLDER RIGHT TO CALL A SPECIAL MEETING (PROPOSAL 4)SHAREHOLDER PROPOSAL GENDER PAY GAP REPORT (PROPOSAL 5)OWNERSHIP OF CIGNA COMMON STOCKSTOCK HELD BY DIRECTORS, NOMINEES AND EXECUTIVE OFFICERSSTOCK HELD BY CERTAIN BENEFICIAL OWNERSANNUAL MEETING INFORMATIONANNEX A NON-GAAP FINANCIAL INFORMATION A-1ANNEX B GENERAL INDUSTRY PEER GROUP B-1